2-Deoxy-D-glucose: Linking Glycolysis Inhibition to Cytoskel
2026-06-29
Explore how 2-Deoxy-D-glucose (2-DG) uniquely bridges glycolysis inhibition with metabolic regulation of the cytoskeleton in cancer and viral research. This cornerstone article delivers in-depth analysis, protocol guidance, and critical insights beyond traditional applications.
Biochemical Characterization of GOB-38 β-Lactamase in E. ano
2026-06-28
This study elucidates the biochemical properties and substrate specificity of the metallo-β-lactamase GOB-38 from Elizabethkingia anophelis, revealing its broad-spectrum hydrolytic activity against multiple β-lactam antibiotics. These findings highlight the enzyme’s role in multidrug resistance and its potential impact on horizontal resistance transfer among hospital pathogens.
YAP-TEAD Control of Super-Enhancer Networks in Ectoderm Fate
2026-06-27
Wang et al. (2026) elucidate how the YAP-TEAD complex orchestrates super-enhancer (SE) networks to regulate early surface ectoderm commitment from pluripotent stem cells. Their integrative use of 3D genomics, histone profiling, and CRISPR-based perturbations advances understanding of lineage specification and provides foundational insight for regenerative medicine and epithelial tissue engineering.
Vidarabine Monohydrate: Molecular Disruption of Viral DNA Sy
2026-06-26
Explore how Vidarabine monohydrate acts as a potent antiviral research compound by directly interfering with viral DNA synthesis. This article uniquely delves into its molecular mechanism, solubility dynamics, and practical assay implications for advanced virology research.
Prevotella copri Depletes Indole-3-Pyruvic Acid to Promote B
2026-06-26
A recent study reveals that Prevotella copri, enriched in the gut microbiota of breast cancer patients, promotes tumor progression by depleting host indole-3-pyruvic acid (IPyA), a physiologically relevant anti-cancer metabolite. This mechanistic insight connects microbiome composition to metabolic regulation of UHRF1 and AMPK signaling, offering new directions for cancer-microbiome research and experimental design.
Sulforaphane (C4733): Mechanistic Insights for Redox and Can
2026-06-25
Explore sulforaphane’s (1-isothiocyanato-4-(methylsulfinyl)-butane) unique role in dissecting redox regulation and cancer chemoprevention at the mechanistic level. This article delivers practical guidance for advanced assay design, illuminating new research frontiers beyond conventional workflows.
Sequential Nanomedicine Remodels Stroma to Inhibit Pancreati
2026-06-25
Fu et al. introduce a multi-stage, acid-responsive nanomedicine that restores stromal homeostasis in pancreatic ductal adenocarcinoma (PDAC), enabling improved gemcitabine delivery and significant tumor regression in vivo. This strategy marks a shift away from stromal ablation toward precise microenvironmental remodeling, with broad implications for overcoming chemoresistance in dense tumors.
TH287 MTH1 Inhibitor: Radiosensitization in Cancer Research
2026-06-24
TH287, a potent MTH1 inhibitor from APExBIO, enables highly selective radiosensitization of resistant cancer cells by exploiting oxidative DNA damage and ATM-p53-mediated responses. New research highlights its protocol-driven synergy with ionizing radiation, paving the way for more effective, targeted cancer therapies.
Fe3O4@ZIF-8 Nanoparticles: Dual Antibiosis and Osteogenesis
2026-06-23
The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a multifunctional platform for jaw osteomyelitis, uniquely integrating potent antibacterial action with bone regeneration capabilities. By leveraging pH-responsive Zn2+ release and magnetic field synergy, this approach addresses persistent infection and bone defect repair challenges, marking a significant advance for translational infection therapy.
DOTAP (1,2-Dioleoyl-3-trimethylammonium-propane chloride): P
2026-06-23
Explore the unique capabilities of 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) as a cationic lipid for precision gene delivery and lipid nanoparticle optimization. This article delves into the mechanistic insights and practical implications of DOTAP, offering a deeper analytical perspective for advanced functional genomics research.
Lanabecestat (AZD3293): Synaptic-Sparing BACE1 Inhibition in
2026-06-22
Lanabecestat (AZD3293) advances Alzheimer's disease research by enabling potent, blood-brain barrier-penetrant BACE1 inhibition while preserving synaptic function. This article integrates mechanistic insights, peer-reviewed evidence, and strategic guidance, empowering translational researchers to optimize amyloid-beta modulation without compromising neural integrity. We synthesize recent findings, protocol parameters, and forward-looking perspectives—escalating the discussion beyond conventional product summaries and providing actionable recommendations for impactful preclinical workflows.
Technical Guidance for Cathepsin B Inhibitor CA-074 (A1926)
2026-06-22
Cathepsin B inhibitor CA-074 is a highly selective small molecule for dissecting cathepsin B-mediated pathways in cancer metastasis, neurotoxicity, and immune response research. It should be applied when nanomolar specificity is critical and broad-spectrum cysteine protease inhibition is not desired. CA-074 is not intended for long-term solution storage or for studies requiring inhibition of cathepsins H or L.
Anlotinib Hydrochloride in IADSRCT: Case Evidence and Resear
2026-06-21
This article examines the first documented use of anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in treating intra-abdominal desmoplastic small round cell tumor (IADSRCT). The case report demonstrates notable tumor regression and manageable toxicity, offering new insights for rare sarcoma management and translational angiogenesis research.
HyperFluor™ 594 Goat Anti-Rabbit IgG Antibody: Precision in
2026-06-20
The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody streamlines sensitive detection in immunocytochemistry, immunohistochemistry, and flow cytometry. Its high specificity, spectral clarity, and robust conjugate stability address real-world workflow challenges for translational and cell biology research.
Protease Inhibitor Cocktail (100X H₂O, EDTA Plus): Precision
2026-06-19
Explore the pivotal role of the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) as a protein stability enhancer in advanced lipid droplet metabolism assays. This article delivers actionable scientific insights, connecting cutting-edge DFCP1-ATGL research to practical assay optimization with a focus on quantitative workflows.
479 records 15/32 page Previous Next First page 上5页 1112131415 下5页 Last page